Bipolar At-Risk Criteria: An Examination of Which Clinical Features Have Optimal Utility for Identifying Youth at Risk of Early Transition From Depression to Bipolar Disorders
Year: 2016
Type: article
Study design: Observational Study
Abstract: Background: A clinical and research challenge is to identify which depressed youth are at risk of "early transition to bipolar disorders (ET-BD)." This 2-part study (1) examines the clinical utility of previously reported BD at-risk (BAR) criteria in differentiating ET-BD cases from unipolar depression (UP) controls; and (2) estimates the Number Needed to Screen (NNS) for research and general psychiatry settings. Methods: Fifty cases with reliably ascertained, ET-BD I and II cases were matched for gender and birth year with 50 UP controls who did not develop BD over 2 years. We estimated the clinical utility for finding true cases and screening out non-cases for selected risk factors and their NNS. Using a convenience sample (N = 80), we estimated the NNS when adjustments were made to account for data missing from clinical case notes. Results: Sub-threshold mania, cyclothymia, family history of BD, atypical depression symptoms and probable antidepressant-emergent elation, occurred significantly more frequently in ET-BD youth. Each of these "BAR-Depression" criteria demonstrated clinical utility for screening out non-cases. Only cyclothymia demonstrated good utility for case finding in research settings; sub-threshold mania showed moderate utility. In the convenience sample, the NNS for each criterion ranged from ~4 to 7. Conclusions: Cyclothymia showed the optimum profile for case finding, screening and NNS in research settings. However, its presence or absence was only reported in 50% of case notes. Future studies of ET-BD instruments should distinguish which criteria have clinical utility for case finding vs screening.
Source: Schizophrenia Bulletin
Authors: Jan Scott, Steven Marwaha, Aswin Ratheesh, Iain Macmillan, Alison R Yung, Richard Morriss, Ian B Hickie, Andreas Bechdolf
Institutions: King's College London, Newcastle University, University of Warwick, The University of Melbourne, Orygen, Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Greater Manchester Mental Health NHS Foundation Trust, University of Manchester, University of Nottingham, Institute of Mental Health, The University of Sydney, University of Cologne, Vivantes Klinikum, Klinikum im Friedrichshain, Charité – Universitätsmedizin Berlin
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sunovion, National Alliance for Research on Schizophrenia and Depression, National Institute for Health and Care Research, Newcastle University, European Commission, Deutsche Forschungsgemeinschaft, University of Sydney, Bundesministerium für Bildung und Forschung, Universität zu Köln, Servier, H. Lundbeck A/S, National Mental Health Commission, Medical Research Council, Research for Patient Benefit Programme, Cilag
OpenAlex ID: W2549831261
